Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Avecilla ST, Goss C, Bleau S, Tonon J-, Meagher RC. How do I perform hematopoietic progenitor cell selection? Transfusion. 2016;56(5):1008-12.

Faltas BM, Prandi D, Tagawa ST, Molina AM, Nanus DM, Sternberg C, et al. Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nat Genet. 2016;48(12):1490-1499.

Pan J-, Sun Y, Jiang Y-, Bott AJ, Jaber N, Dou Z, et al. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis. Mol Cell. 2016;62(1):149-51.

Pisapia DJ, Rosenblum MK, Lavi E. CD1a Reactivity in Non-neoplastic Adenohypophysis. Am J Surg Pathol. 2016;40(6):812-7.

Halteh P, Magro CM, Lipner SR. Subungual pleomorphic fibroma: a case report and review of the literature. Dermatol Online J. 2016;22(11).

Cushing MM, Asmis L, Calabia C, Rand JH, Haas T. Efficacy of solvent/detergent plasma after storage at 2-8 °C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma. Transfus Apher Sci. 2016;55(1):114-9.

Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, et al. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr. 2016;103(3):851-60.

Patel AD, Schneider Y, Saumoy M, Maltz C, Yeo H, Jessurun J, et al. Idiopathic Myointimal Hyperplasia of the Mesenteric Veins. ACG Case Rep J. 2016;3(4):e84.

Wander SA, Zhao D, Besser AH, Hong F, Wei J, Ince TA, et al. Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy. Breast Cancer Res Treat. 2016;156(2):405-6.

Santo EE, Paik J. FOXO3a & haematopoietic stem cells: Goodbye PI3K, hello SIRT1? Cell Cycle. 2016;15(7):879-80.